Abogen Biosciences is a series c plus startup. 2 investors tracked. Status: possibledead.
Abogen Biosciences is a startup founded in 2019 based in China. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Abogen Biosciences develops innovative RNA-based therapeutics and delivery systems focused on mRNA and RNA interference technologies for treating various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.